Lecture 3 - Pharmacology of asthma Flashcards
what are example of B2-adrenoreceptor drugs?
salbutamol, salmeterol, formoterol which relaxes smooth muscles for symptomatic relief
explain the mechanism by which beta arena receptors cause relaxation of smooth muscle
Beta adrenoceptor agonists activate Gs which in turn promotes the stimulation of adenylyl cyclase. This enzyme catalyses the formation of cyclic AMP. cAMP activates protein kinase A, which can
Inhibit MCLK
Promote calcium efflux by increased protein kinase A.
Inhibit the MPK pathway by phosphorylating and inhibiting Raf-1 kinase
The net effect is relaxation of the bronchial smooth muscle and therefore bronchodilation
Explain what long acting beta-adrenoreceptor agonist have?
the long acting beta-adrenoreceptor agonist have lipophilic groups attached which interact with exo-sites on the receptor. this locks the ligand onto the receptor binding site.
describe the difference between salmeterol vs salbutamol
Highly potent 10-11M vs 10-6M at receptor (need to use less)
Binds for longer/more strongly to the receptor.
Longer action 12hr vs 4hrs
Less desensitisation – we will come back to this
what are other actions of beta-adrenoreceptors?
Cholinergic transmission.
Inhibition of inflammatory mediator release.
Vascular permeability.
Mucociliary clearance
explain what effects B2-agonsist (salbutamol) have.
decrease mediator release via mast cells, eosinophils and neutrophils and epithelial cells
dearest cytokine release vis T lymphocytes
decrease neuropeptide release via sensory nerve
what’s a major problem with B2-adrenoreceptor agonist?
short action - desensitisation (loss in response to the agonist over time)
what three mechanisms is desensitisation brought about by?
Phosphorylation of the occupied receptor by a specific receptor kinase, termed b-adrenoceptor kinase (b-ARK)
Internalisation of the receptor.
Phosphorylation of the occupied receptor by protein kinase A; e.g. negative feedback.
what does evidence suggest about salmeterol?
longer acting - due to partial agonist :
Less phosphorylation of the receptor by Beta adrenoceptor kinase (b-ARK)
Less internalisation of the Beta -2 adrenoceptor
The same amount of cAMP/PKA dependent phosphorylation of the receptor
what are routes of administration of the B2-adrenoreceptor drugs?
Inhaled route. A metered dose inhaler is commonly used. Only 10% of the drug enters the lung. For people who cannot use metered inhalers, others include nebulisers and dry powder inhalers.
Oral route. Side-effects make this route a last option. However, some argue that this path is more effective for small airway bronchodilation.
Intravenous and intramuscular. Necessary for acute asthma (risk of death). Given as a drip or as a bolus injection. Most commonly used with terbutaline.
what are the systemic delivery issues with B2-adrenoreceptor agonist?
b2-adrenoceptor agonists elicit vasodilation relaxation of vascular smooth muscle.
Increased blood flow and a fall in BP - reflex increased tachycardia and cardiac output.
Increased metabolic processes, including increased glucose, fatty acids, ketone bodies and high-density lipoprotein.
Increase in tremor in skeletal muscle.
what are steroid treatments for asthma treatment?
Glucocorticoids: dampen down many aspects of the inflammation linked with Asthma
Widely used by inhalation (e.g. beclametasone,
budesonide, fluticasone) as prophylactic therapy.
Standard oral steroid is prednisolone
Intravenous steroids are hydrocortisone and methylprednisolone.
what are the effects of steroid on mediators ?
LTC4, LTD4, LTE4 (eosinophils, basophils, and macrophages). Synthesis and Secretion inhibited.
LTB4 formation blocked (mast cells, alveolar macrophages).
histamine formation blocked (mast cells, basophils)
what are corticosteroids carried in the body as?
transcortin
explain the effect of corticosteroids on the primary effector systems cells - alveolar macrophages and endothelial cells
Alveolar macrophages (migration, IgG and complement decreased- reduction in cytokine synthesis)
Endothelial cells (decrease adhesive response, reduction in vascular permeability).